Our blog provides updates on Absolute Antibody’s technologies, products and services. Browse the latest posts to learn about company developments and events.

Transient Antibody Expression Platform Drives Batch-to-Batch Reproducibility for COVID-19 Diagnostic Assay

Large-Scale Production of the First Pig Influenza Antibodies

Developing a Panel of Recombinant Antibody Controls for Cytokine Release Assays

Anti-SARS-CoV-2 Antibody CR3022 Binds to Coronavirus Variants

Ferret Antibodies for Virology Research, including SARS-CoV-2

Partnering with ChromoTek on Nanobody-based Chimeric Antibodies

Anti-CD25 (IL-2 Receptor A) Antibodies

New Antibodies Join the VivopureX™ Collection

LSBio Acquires Absolute Antibody Ltd.

Eurostars Grant for the Treatment of Metastatic Cancer

New Presentation on Animal-Free Recombinant Antibodies

Using Bispecific Antibody Reagents to Further Immunotherapy Research